Simon A Gayther

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. pmc In vitro three-dimensional modeling of fallopian tube secretory epithelial cells
    Kate Lawrenson
    Department of Preventive Medicine, University of Southern California Keck School of Medicine, 1450 Biggy Street, Los Angeles, California
    BMC Cell Biol 14:43. 2013
  2. pmc Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
    Antonis C Antoniou
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK
    Breast Cancer Res 14:R33. 2012
  3. doi request reprint Inherited risk of ovarian cancer and the implications for screening
    Simon A Gayther
    Department of Preventive Medicine, Keck School of Medicine University of Southern California, Los Angeles, CA, USA
    Int J Gynecol Cancer 22:S12-5. 2012
  4. doi request reprint Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer
    Celeste Leigh Pearce
    Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA
    Cancer Epidemiol Biomarkers Prev 22:880-90. 2013
  5. ncbi request reprint Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium
    Martin Köbel
    Authors Affiliations Department of Pathology and Laboratory Medicine Department of Population Health Research, Alberta Health Services Cancer Care and Department of Medical Genetics, University of Calgary, Calgary, Alberta Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada Department of Medical Oncology Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology Division of Biomedical Statistics and Informatics, Department of Health Science Research Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology Division of Epidemiology, Department of Health Science Research, Mayo Clinic, Rochester, Minnesota Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas University of Texas School of Public Health, Houston, Texas Roswell Park Cancer Institute, Buffalo, New York, New York Women s Cancer Research Center, Magee Womens Research Institute, University of Pittsburgh Cancer Institute Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania Gynaecological Cancer Research Centre, Women s Cancer, UCL EGA Institute for Women s Health Department of Pathology, Cancer Institute, UCL, London, United Kingdom and Department of Preventive Medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California
    Cancer Epidemiol Biomarkers Prev 22:1677-86. 2013
  6. pmc Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
    Hui Shen
    USC Epigenome Center, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California 90033, USA
    Nat Commun 4:1628. 2013
  7. pmc Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
    Celeste Leigh Pearce
    Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA
    Lancet Oncol 13:385-94. 2012
  8. ncbi request reprint Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
    Weiva Sieh
    Division of Epidemiology, Department of Health Research and Policy, Stanford University, Stanford, CA, USA
    Lancet Oncol 14:853-62. 2013
  9. pmc Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Susan J Ramus
    Department of Preventive Medicine, Keck School of Medicine, University of Southern California, California, USA
    Hum Mutat 33:690-702. 2012
  10. pmc Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk
    Celeste Leigh Pearce
    Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90033, USA
    Hum Mol Genet 20:2263-72. 2011

Detail Information

Publications10

  1. pmc In vitro three-dimensional modeling of fallopian tube secretory epithelial cells
    Kate Lawrenson
    Department of Preventive Medicine, University of Southern California Keck School of Medicine, 1450 Biggy Street, Los Angeles, California
    BMC Cell Biol 14:43. 2013
    ....
  2. pmc Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
    Antonis C Antoniou
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK
    Breast Cancer Res 14:R33. 2012
    ..2)...
  3. doi request reprint Inherited risk of ovarian cancer and the implications for screening
    Simon A Gayther
    Department of Preventive Medicine, Keck School of Medicine University of Southern California, Los Angeles, CA, USA
    Int J Gynecol Cancer 22:S12-5. 2012
    ....
  4. doi request reprint Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer
    Celeste Leigh Pearce
    Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, USA
    Cancer Epidemiol Biomarkers Prev 22:880-90. 2013
    ..However, the interplay between such risk factors and susceptibility loci has not been studied...
  5. ncbi request reprint Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium
    Martin Köbel
    Authors Affiliations Department of Pathology and Laboratory Medicine Department of Population Health Research, Alberta Health Services Cancer Care and Department of Medical Genetics, University of Calgary, Calgary, Alberta Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada Department of Medical Oncology Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology Division of Biomedical Statistics and Informatics, Department of Health Science Research Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology Division of Epidemiology, Department of Health Science Research, Mayo Clinic, Rochester, Minnesota Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas University of Texas School of Public Health, Houston, Texas Roswell Park Cancer Institute, Buffalo, New York, New York Women s Cancer Research Center, Magee Womens Research Institute, University of Pittsburgh Cancer Institute Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania Gynaecological Cancer Research Centre, Women s Cancer, UCL EGA Institute for Women s Health Department of Pathology, Cancer Institute, UCL, London, United Kingdom and Department of Preventive Medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California
    Cancer Epidemiol Biomarkers Prev 22:1677-86. 2013
    ..Our aim was to evaluate histologic type assessments across the centers participating in the Ovarian Tumor Tissue Analysis (OTTA) consortium using an immunohistochemical (IHC) prediction model...
  6. pmc Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
    Hui Shen
    USC Epigenome Center, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California 90033, USA
    Nat Commun 4:1628. 2013
    ..These findings underscore distinct mechanisms driving different epithelial ovarian cancer histological subtypes...
  7. pmc Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
    Celeste Leigh Pearce
    Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA
    Lancet Oncol 13:385-94. 2012
    ..We undertook an international collaborative study to assess the association between endometriosis and histological subtypes of ovarian cancer...
  8. ncbi request reprint Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
    Weiva Sieh
    Division of Epidemiology, Department of Health Research and Policy, Stanford University, Stanford, CA, USA
    Lancet Oncol 14:853-62. 2013
    ..We examined whether tumour expression of the progesterone receptor (PR) and oestrogen receptor (ER) was associated with subtype-specific survival...
  9. pmc Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Susan J Ramus
    Department of Preventive Medicine, Keck School of Medicine, University of Southern California, California, USA
    Hum Mutat 33:690-702. 2012
    ..The identification of multiple loci modifying ovarian cancer risk may be useful for counseling women with BRCA1 and BRCA2 mutations regarding their risk of ovarian cancer...
  10. pmc Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk
    Celeste Leigh Pearce
    Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90033, USA
    Hum Mol Genet 20:2263-72. 2011
    ..25). IGF2 is emerging as an important gene for ovarian cancer; additional genotyping is warranted to further confirm these associations with IGF2 and to narrow down the region harboring the causal SNP...